Results 191 to 200 of about 126,041 (267)

Glycan-binding properties of SARS-CoV-2 spike proteins: interactions with aminoglycoside antibiotics. [PDF]

Sci Rep
Hatakeyama D, Shoji M, Miki Y, Ueki S, Yamaguchi K, Nakashima K, Tanaka Y, Yokogawa M, Osawa M, Kasai Y, Imagawa H, Hashimoto R, Takayama K, Kuzuhara T.   +13 more
europepmc   +1 more source

v. 83, issue 13, February 25, 2016 [PDF]

, 2016

core   +1 more source

Acute healthcare utilization associated with positive SARS-CoV-2 testing or serology among people experiencing homelessness: A prospective cohort study. [PDF]

PLoS One
Richard L, Carter B, Liu M, Nisenbaum R, Hwang SW.   +4 more
europepmc   +1 more source

Pathological characteristics of SARS-CoV-2 variants and immune responses induced in a COVID-19 macaque model. [PDF]

Commun Biol
Urano E, Okamura T, Higuchi M, Furukawa M, Ueda K, Nagata S, Kamada H, Yasutomi Y.   +7 more
europepmc   +1 more source

Clues to Long COVID Linked to Virulence and Infectivity Found in Shell Proteins. [PDF]

Adv Respir Med
Goh GK, Foster JA, Uversky VN.
europepmc   +1 more source

<b>Broadly cross-reactive mRNA COVID-19 vaccine encoding trimeric RBDs and NSP12 mitigates immune imprinting</b>. [PDF]

Mol Ther Nucleic Acids
De Chiara A, Giachino C, Pirillo MF, Campanile A, Pellino E, Gallinaro A, Froechlich G, Falce C, Scognamiglio A, Totaro S, Liguori MV, Peltrini R, De Simone A, Capone S, Pietro Z, Negri D, Cara A, Nicosia A, Sasso E.   +18 more
europepmc   +1 more source

Impact of First SARS-CoV-2 Infection Variant on Serological Responses Against Omicron: Findings From the SIREN Study. [PDF]

Influenza Other Respir Viruses
Insalata F, Atti A, Carr EJ, Otter AD, SIREN study group, Foulkes S, Dowgier G, Hobbs A, Wu MY, Hopkins S, Charlett A, Beale R, Hall V.   +12 more
europepmc   +1 more source

Engineered IgA-Fc fusion protein with bioactive nanobody neutralizes SARS-CoV-2 variants with mucosal delivery potential. [PDF]

J Biol Chem
Golonka RM, Intravaia LE, Shaqra AM, Li Q, Chen Y, Humphries F, Kurt-Yilmaz N, Fitzgerald KA, Schiffer CA, Wang Y, Cavacini LA.   +10 more
europepmc   +1 more source

Omicron courtyards

, 2015
openaire   +2 more sources

Effectiveness of Inactivated COVID-19 Vaccination Against COVID-19-Related Hospitalization and Severe Outcomes in Adults ≥80 Years During Omicron Circulation in Beijing, China: Retrospective Cohort Study.

JMIR Public Health Surveill
Zhao D, Ma Y, Li J, Li X, Cao Z, Yao W, Wu J, Suo L.   +7 more
europepmc   +1 more source